Epithelial-mesenchymal plasticity in carcinoma metastasis
被引:943
作者:
Tsai, Jeff H.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USAUniv Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA
Tsai, Jeff H.
[1
]
Yang, Jing
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA
Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USAUniv Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA
Yang, Jing
[1
,2
]
机构:
[1] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA
Tumor metastasis is a multistep process by which tumor cells disseminate from their primary site and form secondary tumors at a distant site. Metastasis occurs through a series of steps: local invasion, intravasation, transport, extravasation, and colonization. A developmental program termed epithelial-mesenchymal transition (EMT) has been shown to play a critical role in promoting metastasis in epithelium-derived carcinoma. Recent experimental and clinical studies have improved our knowledge of this dynamic program and implicated EMT and its reverse program, mesenchymal-epithelial transition (MET), in the metastatic process. Here, we review the functional requirement of EMT and/or MET during the individual steps of tumor metastasis and discuss the potential of targeting this program when treating metastatic diseases.